Nature Communications (Jan 2024)
Variants in the WDR44 WD40-repeat domain cause a spectrum of ciliopathy by impairing ciliogenesis initiation
- Andrea Accogli,
- Saurabh Shakya,
- Taewoo Yang,
- Christine Insinna,
- Soo Yeon Kim,
- David Bell,
- Kirill R. Butov,
- Mariasavina Severino,
- Marcello Niceta,
- Marcello Scala,
- Hyun Sik Lee,
- Taekyeong Yoo,
- Jimmy Stauffer,
- Huijie Zhao,
- Chiara Fiorillo,
- Marina Pedemonte,
- Maria C. Diana,
- Simona Baldassari,
- Viktoria Zakharova,
- Anna Shcherbina,
- Yulia Rodina,
- Christina Fagerberg,
- Laura Sønderberg Roos,
- Jolanta Wierzba,
- Artur Dobosz,
- Amanda Gerard,
- Lorraine Potocki,
- Jill A. Rosenfeld,
- Seema R. Lalani,
- Tiana M. Scott,
- Daryl Scott,
- Mahshid S. Azamian,
- Raymond Louie,
- Hannah W. Moore,
- Neena L. Champaigne,
- Grace Hollingsworth,
- Annalaura Torella,
- Vincenzo Nigro,
- Rafal Ploski,
- Vincenzo Salpietro,
- Federico Zara,
- Simone Pizzi,
- Giovanni Chillemi,
- Marzia Ognibene,
- Erin Cooney,
- Jenny Do,
- Anders Linnemann,
- Martin J. Larsen,
- Suzanne Specht,
- Kylie J. Walters,
- Hee-Jung Choi,
- Murim Choi,
- Marco Tartaglia,
- Phillippe Youkharibache,
- Jong-Hee Chae,
- Valeria Capra,
- Sung-Gyoo Park,
- Christopher J. Westlake
Affiliations
- Andrea Accogli
- Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre (MUHC)
- Saurabh Shakya
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Taewoo Yang
- Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University
- Christine Insinna
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Soo Yeon Kim
- Department of Genomic Medicine, Seoul National University Hospital
- David Bell
- Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research
- Kirill R. Butov
- Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Mariasavina Severino
- Neuroradiology Unit, IRCCS Istituto Giannina Gaslini
- Marcello Niceta
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS
- Marcello Scala
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova
- Hyun Sik Lee
- School of Biological Sciences, Seoul National University
- Taekyeong Yoo
- Department of Biomedical Sciences, Seoul National University College of Medicine
- Jimmy Stauffer
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Huijie Zhao
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Chiara Fiorillo
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova
- Marina Pedemonte
- Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini
- Maria C. Diana
- Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini
- Simona Baldassari
- Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini
- Viktoria Zakharova
- National Medical Research Center for Endocrinology, Clinical data analysis department
- Anna Shcherbina
- Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Yulia Rodina
- Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Christina Fagerberg
- Department of Clinical Genetics, Odense University Hospital
- Laura Sønderberg Roos
- Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital
- Jolanta Wierzba
- Department of Pediatrics and Internal Medicine Nursing, Department of Rare Disorders, Medical University of Gdansk
- Artur Dobosz
- Department of Medical Genetics, Faculty of Medicine, Jagiellonian University Medical College
- Amanda Gerard
- Texas Children’s Hospital
- Lorraine Potocki
- Texas Children’s Hospital
- Jill A. Rosenfeld
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Seema R. Lalani
- Texas Children’s Hospital
- Tiana M. Scott
- Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine
- Daryl Scott
- Baylor Genetics Laboratories
- Mahshid S. Azamian
- Baylor Genetics Laboratories
- Raymond Louie
- Greenwood Genetic Center
- Hannah W. Moore
- Greenwood Genetic Center
- Neena L. Champaigne
- Greenwood Genetic Center
- Grace Hollingsworth
- Greenwood Genetic Center
- Annalaura Torella
- Telethon Institute of Genetics and Medicine (TIGEM)
- Vincenzo Nigro
- Telethon Institute of Genetics and Medicine (TIGEM)
- Rafal Ploski
- Department of Medical Genetics, Medical University of Warsaw
- Vincenzo Salpietro
- Department of Neuromuscular Disorders, Queen Square Institute of Neurology, University. College London
- Federico Zara
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova
- Simone Pizzi
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS
- Giovanni Chillemi
- Department for Innovation in Biological, Agro-food and Forest systems, DIBAF, University of Tuscia, Via S. Camillo de Lellis s.n.c
- Marzia Ognibene
- Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini
- Erin Cooney
- Division of Medical Genetics and Metabolism, Department of Pediatrics, University of Texas Medical Branch
- Jenny Do
- Division of Medical Genetics and Metabolism, Department of Pediatrics, University of Texas Medical Branch
- Anders Linnemann
- Hans Christian Andersen Children’s Hospital, Odense University Hospital
- Martin J. Larsen
- Department of Clinical Genetics, Odense University Hospital
- Suzanne Specht
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Kylie J. Walters
- Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Hee-Jung Choi
- School of Biological Sciences, Seoul National University
- Murim Choi
- Department of Biomedical Sciences, Seoul National University College of Medicine
- Marco Tartaglia
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS
- Phillippe Youkharibache
- Cancer Science Data Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Jong-Hee Chae
- Department of Genomic Medicine, Seoul National University Hospital
- Valeria Capra
- Child Neuropsychiatry, IRCCS Istituto G.Gaslini, DINOGMI University of Genova
- Sung-Gyoo Park
- Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University
- Christopher J. Westlake
- Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- DOI
- https://doi.org/10.1038/s41467-023-44611-2
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 20
Abstract
Abstract WDR44 prevents ciliogenesis initiation by regulating RAB11-dependent vesicle trafficking. Here, we describe male patients with missense and nonsense variants within the WD40 repeats (WDR) of WDR44, an X-linked gene product, who display ciliopathy-related developmental phenotypes that we can model in zebrafish. The patient phenotypic spectrum includes developmental delay/intellectual disability, hypotonia, distinct craniofacial features and variable presence of brain, renal, cardiac and musculoskeletal abnormalities. We demonstrate that WDR44 variants associated with more severe disease impair ciliogenesis initiation and ciliary signaling. Because WDR44 negatively regulates ciliogenesis, it was surprising that pathogenic missense variants showed reduced abundance, which we link to misfolding of WDR autonomous repeats and degradation by the proteasome. We discover that disease severity correlates with increased RAB11 binding, which we propose drives ciliogenesis initiation dysregulation. Finally, we discover interdomain interactions between the WDR and NH2-terminal region that contains the RAB11 binding domain (RBD) and show patient variants disrupt this association. This study provides new insights into WDR44 WDR structure and characterizes a new syndrome that could result from impaired ciliogenesis.